Parkinson drug development halted as Biogen and Denali stop BIIB122 after phase 2b trial failed to slow disease progression.

In this week’s edition of InnovationRx, we look at a new AI drug development deal, a pill for sleep apnea, Commure’s $7 ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

When Daniel Haders, Ph.D., was working in venture capital, he was on the hunt for an AI-driven drug discovery company that ...

VANCOUVER, BC / ACCESS Newswire / May 22, 2026 / Redwood AI Corp. (CSE:AIRX)(OTCQB:RDWCF)(Frankfurt:Y0N, WKN: A422EZ) ("Redwood" or the "Company") is pleased to announce that it has entered into a ...

Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag of clinical AI, digital health at the FDA, and the boom in direct-to-consumer ...

Jindal served as governor of Louisiana and as a U.S. assistant secretary of Health and Human Services. Katebi is deputy director of the Center for a Healthy America at the America First Policy ...